Recent

% | $
Quotes you view appear here for quick access.

Sprint Corporation Message Board

stevencath 124 posts  |  Last Activity: Jul 16, 2013 2:31 PM Member since: Aug 9, 2009
  • stevencath@sbcglobal.net by stevencath Jul 16, 2013 2:31 PM Flag

    Estimates may be LOW!
    Earnings Est Current Qtr.
    Jun 13 Next Qtr.
    Sep 13 Current Year
    Dec 13 Next Year
    Dec 14
    Avg. Estimate 1.00 1.07 3.96 4.84
    No. of Analysts 7.00 7.00 6.00 7.00
    Low Estimate 0.76 0.84 3.29 4.07
    High Estimate 1.18 1.31 4.66 6.52

    Sentiment: Strong Buy

  • This is new(but old, June-11-13, buy drug). The biotech(Novartis Drugs) announced that it has sold rights Syncathen and Synacthen Depot in the U.S. While the initial deal involves U.S. rights, Questcor also expects to gain rights for Synacthen in more than three dozen other countries.

    Sentiment: Strong Buy

  • stevencath@sbcglobal.net by stevencath Jul 16, 2013 2:01 PM Flag

    This is major!
    Sarcoidosis is a systemic inflammatory disease that involves the abnormal collection of chronic inflammatory cells, called granulomas, that often form as nodules in the lungs -- when they do, the disease is known as pulmonary sarcoidosis. The lungs can become stiff and may not be able to hold as much air as healthy lungs, and in the worst of cases, sarcoidosis causes the formation of scar tissue. Sarcoidosis, says Questcor, affects 150,000 Americans, and 90% of cases are pulmonary. The company anticipates hiring and training a pilot sales force for the indication in the third quarter, with sales calls beginning in the fourth quarter of 2013. If Acthar catches on in pulmonary sarcoidosis for steroid-intolerant/refractory patients, it will be entering a sizable market with significant implications for the top-line.
    This is major!

    Sentiment: Strong Buy

  • “We believe (MetroPCS) could receive a bid from Sprint within the next one to four weeks, likely in the $12-13 per share range,” writes Guggenheim analyst Shing Yin in a Friday research note.

    Sentiment: Strong Buy

  • I believe we'll see $6 by year end and the rise started this week.....

    Sentiment: Strong Buy

  • “We believe (MetroPCS) could receive a bid from Sprint within the next one to four weeks, likely in the $12-13 per share range,” writes Guggenheim analyst Shing Yin in a Friday research note.

    Sentiment: Strong Sell

  • Questcor Pharmaceuticals' (Nasdaq: QCOR )-------- recent dilemma. Insurance reimbursement and government investigation concerns have caused considerable investor doubts around the stock.------------ While both Spectrum and Questcor appear cheap using traditional valuation metrics, --------these risks will are likely to continue.!!!!!!!!!!

    Sentiment: Strong Sell

  • stevencath@sbcglobal.net by stevencath Nov 28, 2012 8:33 PM Flag

    Questcor Pharmaceuticals' (Nasdaq: QCOR )-------- recent dilemma. Insurance reimbursement and government investigation concerns have caused considerable investor doubts around the stock.------------ While both Spectrum and Questcor appear cheap using traditional valuation metrics, --------these risks will are likely to continue.!!!!!!!!!!

    Sentiment: Strong Sell

  • stevencath@sbcglobal.net by stevencath Nov 19, 2012 1:16 PM Flag

    All The Right Moves; Steps Taken By Sprint Signify Further Upside Potential
    November 19, 2012 by: Qineqt |

    Sentiment: Strong Buy

  • Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (QCOR) securities between April 26, 2011 and September 21, 2012. May hurt the company now until the court is done, Nov. 26, 2012.

    Sentiment: Strong Sell

  • The early weakness in shares of Questcor is being attributed to Cerium Pharmaceuticals this week receiving Orphan status for its infantile spasms treatment. Questcor's Acthar gel is used as a treatment for infantile spasms.

    Sentiment: Strong Sell

  • Sprint is worth over $ 7.00 per share!!!!!!!!!!!!!!!!!!!!!
    The sell of Sprint at $20 Billion of 70% of the company it is :
    70% = $20 Billion
    30% = $12 Billion
    100% = $32 Billion = $32 Divided 3 Billion shares = $10.7 each, these shares should be traded at $10.7 !

    First, came news that Crest Financial and Mount Kellet Capital Management (two large Clearwire shareholders) sent letters to Clearwire's board to sell some spectrum to raise capital and prevent Sprint from undermining Clearwire's investors. I see their point of view, but do not agree with their conclusion that Clearwire needs to sell some of its vast spectrum to keep Sprint at bay. Clearwire's spectrum is why Son gave Sprint $20 Billion for 48% of Clearwire and Clearwire should not sell any of its vast spectrum at this point. If you wish to read about my reasoning for Son acquiring Sprint for Clearwire's spectrum and not for Sprint's massive debts I wrote this Clearwire article a few weeks ago.
    Second, came news that US Cellular was selling some of its Midwestern markets and Spectrum to Sprint in a $480 Million deal. Now why would Sprint need more spectrum when Clearwire is drowning in spectrum and Sprint recently announced delays in its 4G rollout?
    Third, on Thursday Sprint announced that it is open to hosting Dish's spectrum on its network. Sprint only months ago sent a letter to the FCC asking for restrictions on Dish's use of the AWS 4 spectrum
    Stocks advance or decline due to a catalyst that propels a stock. As you can see Sprint's year end quarter will be strong and for those wanting to go longer they will have Sprint stock price at a set price of no lower than the $7.30 Softbank has agreed to pay to buyout Sprint investors. Now you see why institutional investors already own 90% of Sprint's stock.

    Sentiment: Strong Buy

  • Wall St. Watchdog reveals information about companies for which stock analysts upgraded the shares on October 17th.
    Sprint Nextel (NYSE:S): Argus upgraded its rating on this company from Hold to Buy and changed its price target to $7.5
    Sprint fell 1.3 percent to $5.65 in afternoon trading after surging last week on the first reports of a pending deal. The offer, while a substantial premium, is still less than some observers had hoped.
    A fund manager at T. Rowe Price, a top-15 Sprint shareholder, told Reuters last week he thought Sprint would be worth $10 a share in 18 months
    The sell of Sprint at $20 Billion of 70% of the company it is :
    70% = $20 Billion
    30% = $12 Billion
    100% = $32 Billion = $32 Divided 3 Billion shares = $10.7 each, these shares should be traded at $10.7 !!
    Sprint Nextel CEO Buys 20K Shares and 4 Insider Trades Not to Miss
    October 30, 2012
    Wall St. Watchdog reveals information about insider trades in the constituent companies of the S&P 500 for October 26th.
    HESSE DANIEL who is President & CEO at Sprint Nextel Corp. (NYSE:S), bought 20,000 shares at $5.53 per share for a total value of $110,600. The shares recently traded at $5.49, down $0.04, or 0.72% sincethe insider buying

    Sentiment: Strong Buy

  • stevencath@sbcglobal.net by stevencath Nov 8, 2012 5:32 PM Flag

    The Voice on channel NBC w/SPRINT used!!!!!!!!!!!!!!!( also a large add)

    Sentiment: Strong Buy

  • The early weakness in shares of Questcor is being attributed to Cerium Pharmaceuticals this week receiving Orphan status for its infantile spasms treatment. Questcor's Acthar gel is used as a treatment for infantile spasms.

    Sentiment: Strong Sell

  • stevencath@sbcglobal.net by stevencath Nov 8, 2012 12:01 PM Flag

    Wall St. Watchdog reveals information about companies for which stock analysts upgraded the shares on October 17th.
    Sprint Nextel (NYSE:S): Argus upgraded its rating on this company from Hold to Buy and changed its price target to $7.5
    Sprint fell 1.3 percent to $5.65 in afternoon trading after surging last week on the first reports of a pending deal. The offer, while a substantial premium, is still less than some observers had hoped.
    A fund manager at T. Rowe Price, a top-15 Sprint shareholder, told Reuters last week he thought Sprint would be worth $10 a share in 18 months
    The sell of Sprint at $20 Billion of 70% of the company it is :
    70% = $20 Billion
    30% = $12 Billion
    100% = $32 Billion = $32 Divided 3 Billion shares = $10.7 each, these shares should be traded at $10.7 !!


    Sprint Nextel CEO Buys 20K Shares and 4 Insider Trades Not to Miss
    October 30, 2012
    Wall St. Watchdog reveals information about insider trades in the constituent companies of the S&P 500 for October 26th.
    HESSE DANIEL who is President & CEO at Sprint Nextel Corp. (NYSE:S), bought 20,000 shares at $5.53 per share for a total value of $110,600. The shares recently traded at $5.49, down $0.04, or 0.72% sincethe insider buy.

    Sentiment: Strong Buy

  • Sprint Upgraded to Buy and 4 Upgraded Shares Seeing Action
    By Alex Capel | More Articles
    October 17, 2012
    Wall St. Watchdog reveals information about companies for which stock analysts upgraded the shares on October 17th.
    Sprint Nextel (NYSE:S): Argus upgraded its rating on this company from Hold to Buy and changed its price target to $7.5
    Sprint fell 1.3 percent to $5.65 in afternoon trading after surging last week on the first reports of a pending deal. The offer, while a substantial premium, is still less than some observers had hoped.
    A fund manager at T. Rowe Price, a top-15 Sprint shareholder, told Reuters last week he thought Sprint would be worth $10 a share in 18 months
    The sell of Sprint at $20 Billion of 70% of the company it is :
    70% = $20 Billion
    30% = $12 Billion
    100% = $32 Billion = $32 Divided 3 Billion shares = $10.7 each, these shares should be traded at $10.7 !!

    Sprint Nextel CEO Buys 20K Shares and 4 Insider Trades Not to Miss
    October 30, 2012
    Wall St. Watchdog reveals information about insider trades in the constituent companies of the S&P 500 for October 26th.
    HESSE DANIEL who is President & CEO at Sprint Nextel Corp. (NYSE:S), bought 20,000 shares at $5.53 per share for a total value of $110,600. The shares recently traded at $5.49, down $0.04, or 0.72% since the insider buy.

    Sentiment: Strong Buy

  • Sprint Upgraded to Buy and 4 Upgraded Shares Seeing Action
    By Alex Capel | More Articles
    October 17, 2012
    Wall St. Watchdog reveals information about companies for which stock analysts upgraded the shares on October 17th.
    Sprint Nextel (NYSE:S): Argus upgraded its rating on this company from Hold to Buy and changed its price target to $7.5
    Sprint fell 1.3 percent to $5.65 in afternoon trading after surging last week on the first reports of a pending deal. The offer, while a substantial premium, is still less than some observers had hoped.
    A fund manager at T. Rowe Price, a top-15 Sprint shareholder, told Reuters last week he thought Sprint would be worth $10 a share in 18 months
    The sell of Sprint at $20 Billion of 70% of the company it is :
    70% = $20 Billion
    30% = $12 Billion
    100% = $32 Billion = $32 Divided 3 Billion shares = $10.7 each, these shares should be traded at $10.7 !!
    Sprint Nextel CEO Buys 20K Shares and 4 Insider Trades Not to Miss
    October 30, 2012
    Wall St. Watchdog reveals information about insider trades in the constituent companies of the S&P 500 for October 26th.
    HESSE DANIEL who is President & CEO at Sprint Nextel Corp. (NYSE:S), bought 20,000 shares at $5.53 per share for a total value of $110,600. The shares recently traded at $5.49, down $0.04, or 0.72% since the insider buy.

    Sentiment: Strong Buy

  • Sprint Upgraded to Buy and 4 Upgraded Shares Seeing Action
    By Alex Capel | More Articles
    October 17, 2012
    Wall St. Watchdog reveals information about companies for which stock analysts upgraded the shares on October 17th.
    Sprint Nextel (NYSE:S): Argus upgraded its rating on this company from Hold to Buy and changed its price target to $7.5
    Sprint fell 1.3 percent to $5.65 in afternoon trading after surging last week on the first reports of a pending deal. The offer, while a substantial premium, is still less than some observers had hoped.
    A fund manager at T. Rowe Price, a top-15 Sprint shareholder, told Reuters last week he thought Sprint would be worth $10 a share in 18 months
    The sell of Sprint at $20 Billion of 70% of the company it is :
    70% = $20 Billion
    30% = $12 Billion
    100% = $32 Billion = $32 Divided 3 Billion shares = $10.7 each, these shares should be traded at $10.7 !!


    Sprint Nextel CEO Buys 20K Shares and 4 Insider Trades Not to Miss
    October 30, 2012
    Wall St. Watchdog reveals information about insider trades in the constituent companies of the S&P 500 for October 26th.
    HESSE DANIEL who is President & CEO at Sprint Nextel Corp. (NYSE:S), bought 20,000 shares at $5.53 per share for a total value of $110,600. The shares recently traded at $5.49, down $0.04, or 0.72% since the insider buy.

    Sentiment: Strong Buy

  • Sprint Upgraded to Buy and 4 Upgraded Shares Seeing Action
    By Alex Capel | More Articles
    October 17, 2012
    Wall St. Watchdog reveals information about companies for which stock analysts upgraded the shares on October 17th.
    Sprint Nextel (NYSE:S): Argus upgraded its rating on this company from Hold to Buy and changed its price target to $7.5
    Sprint fell 1.3 percent to $5.65 in afternoon trading after surging last week on the first reports of a pending deal. The offer, while a substantial premium, is still less than some observers had hoped. A fund manager at T. Rowe Price, a top-15 Sprint shareholder, told Reuters last week he thought Sprint would be worth $10 a share in 18 months
    The sell of Sprint at $20 Billion of 70% of the company it is :
    70% = $20 Billion
    30% = $12 Billion
    100% = $32 Billion = $32 Divided 3 Billion shares = $10.7 each, these shares should be traded at $10.7 !!

    Sentiment: Strong Buy

S
3.51-0.060(-1.68%)May 24 4:02 PMEDT